<DOC>
	<DOCNO>NCT01299324</DOCNO>
	<brief_summary>The primary objective feasibility study provide clinical data demonstrate safety activity concentrate nucleate cell bone marrow aspirate ( BMAC ) produce Harvest Bone Marrow Aspirate Concentrate System treat patient diagnose congestive heart failure ( CHF ) .</brief_summary>
	<brief_title>Retrograde Delivery BMAC ( Bone Marrow Aspirate Concentrate ) Congestive Heart Failure</brief_title>
	<detailed_description>To demonstrate infusion bone marrow nucleate cell coronary sinus safe assessed adverse event record . To assess effect infusion bone marrow nucleate cell clinical course angina heart failure measure QOL questionnaire , Minnesota Living Heart Failure , NYHA CCS classification SPECT . To assess effect infusion bone marrow nucleate cell heart function measure ejection fraction ( EF ) leave ventricular end-diastolic diameter ( LVEDD ) ECHO . To assess effect infusion bone marrow nucleate cell area ischemia measure myocardial SPECT study ECHO .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Age ≥18 year ability understand plan treatment . Patients Congestive Heart Failure Left ventricular ejection fraction ≤40 % echocardiogram , per ECHO complete 30 day prior treatment Symptomatic heart failure NYHA class III IV Able comply studyrelated visit Able tolerate study procedure , include bone marrow aspiration , SPECT , Able give inform Consent Negative HcG serum pregnancy test Patients control diabetes mellitus ( HbA1c &lt; 9.0 % ) Hematocrit ≥ 28.0 % , White Blood Cell count ≤ 14,000 , Platelet count ≥ 50,000 , Life expectancy 6 month opinion investigator Patients require high dose corticosteroid therapy ( 7.5 mg/day ) 1 month aspiration 6 month infusion . Serum bilirubin , ALT , AST ≤2.5 time upper level normal . Controlled blood pressure ( systolic blood pressure ≤140 diastolic blood pressure ≤90 mmHG ) establish antihypertensive therapy necessary prior entry study Patient receive stable , standard medical therapy least one month new medication treat disease introduce last 3 month . Preexisting condition ( e.g . thromboembolic risk , diabetes , hypercholesterolemia adequately controlled opinion investigator ) Fertile patient ( male female ) must agree use appropriate form contraception participate study . Female pregnant nursing , child bear potential use reliable birth control method , intend become pregnant tenure study . History prior radiation exposure oncological treatment . History Bone Marrow Disorder ( especially NHL , MDS ) prohibit transplantation . History abnormal bleeding clotting . History Liver Cirrhosis . End stage renal disease ( Creatinine ≤ 3.0 mg / dl ) and/or dialysis Acute Myocardial Infarction &lt; 1 week treatment date . Active clinical infection treat antibiotic within one week enrollment Inability unwillingness comply treatment protocol , followup , research test , give consent . Unable 250cc bone marrow harvest . History lifethreatening arrhythmia , except automate implantable cardioverter defibrillator ( AICD ) implant Life expectancy &lt; 6 month due concomitant illness Known cancer undergo treatment ; chemotherapy and/or radiotherapy Patients receive treatment hematopoietic growth factor ( e.g. , EPO , GCSF ) Patients stop anticoagulation therapy ( warfarin ) 72hrs prior bone marrow aspiration infusion Patients stop antiplatelet therapy ( clopidogrel ) 7 day prior bone marrow aspiration infusion History alcohol consumption exceed equivalent 2 drinks/daily ( 1 drink = 5oz wine , 12oz beer , 1.5oz hard liquor ) illicit drug use within 6 month screen . Patient require continuous high dose corticosteroid therapy ( 7.5mg/day ) within 1 month aspiration 6 month injection procedure . Body Mass Index ( BMI ) 40 kg/m2 great Patient receive experimental medication participate another clinical study within 30 day sign informed consent In opinion investigator sponsor , patient unsuitable cellular therapy Known allergy sensitivity contrast agent use image procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>CHF</keyword>
</DOC>